Statistics

Total Visits

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.80

Select a period of time:

Number of views in the range

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.43

Views

Views
June 20257
July 202526
August 20250
September 20254
October 20253
November 20251
December 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil15
Hong Kong10
United Kingdom8
United States5
Morocco2
Argentina1
Trinidad and Tobago1
Uruguay1
 

Top cities views

Views
Hong Kong10
São Paulo2
Alta Floresta1
Barcarena Nova1
Bauru1
Caicó1
Casablanca1
Dallas1
Dayton1
Detroit1